News

Media

Conferences

Publications

Clinical

Events

Resources

Article

September 25, 2015

Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy

Author(s):

Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/colon-cancer-multiple-myeloma-drug-development-hig" target="_blank">View the story "Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy" on Storify</a>]

Related Videos

Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.

Image Credit: © alenamozhjer - stock.adobe.com

pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix

pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought

Image Credit: © Andrey Popov - stock.adobe.com

Image Credit: © peopleimages.com - stock.adobe.com

TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC

World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.